Here’s what you should know:
1. President Trump made the prediction at the end of May.
2. HHS Secretary Alex Azar tried to distance the administration from the two-week timeline by saying drug companies were facing hurdles in their efforts to cut costs.
3. Deputy White House Press Secretary Hogan Gidley said, “We’re not going to get ahead of any forthcoming announcements.”
4. The White House alleged companies have been working to lower their drug prices for the last year. The Washington Post said the lack of action following several of President Trump’s promises suggests the price decreases could still be a ways away.
More articles on supply chain:
TVA Medical to introduce FDA-approved endovascular fistula creation method at surgery centers — 5 insights
Implementing a total joint replacement program in your ASC: 4 lessons from OrthoIllinois Surgery Center
30k joint replacements for SurgCenter Development & more — 8 ASC company key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.